Meshalkin Research Institute of Pathology of Circulation: Coronary Artery Disease trials

The registry lists 18 Coronary Artery Disease studies with Meshalkin Research Institute of Pathology of Circulation as lead sponsor. 1 are open to participants now and 1 have results posted.

Phase 2 3Phase 3 5No phase 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Study of the No-touch Saphenous Vein GraftRecruitingNCT05757947Not applicable
• The Efficacy and Safety of Hypertonic Saline in Cardiac Surgery Patients.CompletedNCT01675453Phase 2Results posted
• A Study of Drug Coated Balloon For Treating the Side Branch in Complex Bifurcation LesionsStatus unknownNCT05222061Not applicable
• Total Arterial Revascularization (TAR)Status unknownNCT03753048Not applicable
• TEmporary Spinal CoRd StiMulatIon to PrevenNt Atrial FibrillaTION AFter Cardiac SurgeryStatus unknownNCT03539354Not applicable
• StEnt Coverage and Neointimal Tissue Characterization After eXtra Long evErolimus - Eluting Stent imPlantationStatus unknownNCT03401216Not applicable
• Communicational Program "Trust" to Improve Adherence to MedicationsStatus unknownNCT03268291Not applicable
• "TransRadial Ultra Support Technique" (TRUST)CompletedNCT03025685Not applicable
• Epicardial Fat Pads Ablation During Coronary SurgeryStatus unknownNCT02984371Phase 2
• The New Pharmaceutical Composition Containing Botulinum Toxin to Treat Atrial FibrillationStatus unknownNCT02982434Phase 2
• Efficacy and Safety of Aspirin Therapy With CABGStatus unknownNCT02942680Phase 3
• Stress-MRI Assessment After Right Coronary Artery CTO RecanalizationCompletedNCT02769650Not applicable
• T-provisional Stenting vs Mini-Crush in Chronic Total Occlusions (CTO)CompletedNCT02708329Not applicable
• Sirolimus-eluting Stent CALYPSO vs Everolimus-eluting Stent XIENCECompletedNCT02681016Not applicable
• The Assessment of Progression of Paroxysmal AF After CABGStatus unknownNCT02246803Phase 3
• Surgical Ablation of Long-standing Persistent AF During CABGStatus unknownNCT02246790Phase 3
• Effects of Glutamine in Ischemic Heart Disease Patients Following Cardiopulmonary BypassCompletedNCT01478126Phase 3
• Omega 3 Fatty Acid Efficiency for Prevention of Atrial Fibrillation After Coronary Artery Bypass GraftingTerminatedNCT01175330Phase 3